CORC

在结果中检索

CORC

浏览/检索结果: 共91条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with conventional taxanes in women with breast cancer: a systematic review and meta-analysis 期刊论文
ANNALS OF PALLIATIVE MEDICINE, 2022, 卷号: 11
作者:  Lei, Lei;  Chen, Rucheng;  Fan, Lei;  Zheng, Weijun;  Wang, Xiaojia
收藏  |  浏览/下载：19/0  |  提交时间：2022/12/23
Pyrotinib or Lapatinib Combined With Capecitabine in HER2-Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II Study 期刊论文
2019, 卷号: 37, 期号: 29, 页码: 2610-2619
作者:  Ma Fei;  Ouyang Quchang;  Li Wei;  Jiang Zefei;  Tong Zhongsheng
收藏  |  浏览/下载：32/0  |  提交时间：2020/01/03
Synthesis and biological evaluation of novel larotaxel analogues 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 156, 页码: 692-710
作者:  Ren, Sumei;  Wang, Yujie;  Wang, Junfei;  Gao, Dingding;  Zhang, Minmin
收藏  |  浏览/下载：27/0  |  提交时间：2019/01/08
Oral Administration of Prunella vulgaris L Improves the Effect of Taxane on Preventing the Progression of Breast Cancer and Reduces Its Side Effects 期刊论文
FRONTIERS IN PHARMACOLOGY, 2018, 卷号: 9
作者:  Zhao, Jixue;  Ji, Degang;  Zhai, Xujie;  Zhang, Lirong;  Luo, Xiao
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 期刊论文
CANCER RESEARCH, 2018, 卷号: 78, 期号: 4
作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 会议论文
作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
Phase 2 Study of Cyclophosphamide, Etoposide, and Estramustine in Patients With Castration-Resistant Prostate Cancer 期刊论文
CLINICAL GENITOURINARY CANCER, 2018, 卷号: 16, 期号: 6, 页码: 473-481
作者:  Laber, Damian A.[1];  Chen, Min-Bin[2];  Jaglal, Michael[3];  Patel, Ankita[4];  Visweshwar, Nathan[5]
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/24
A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 会议论文
CANCER RESEARCH, 2018-02-01
作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei
收藏  |  浏览/下载：15/0  |  提交时间：2020/01/03
A randomized phase II trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer previously treated with taxanes, anthracyclines and/or trastuzumab 期刊论文
2018, 卷号: 78, 期号: 4
作者:  Xu, Binghe;  Ma, Fei;  Ouyang, Quchang;  Li, Wei;  Jiang, Zefei
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03
Genetic polymorphisms of autophagy-related gene 5 (ATG5) rs473543 predict different disease-free survivals of triple-negative breast cancer patients receiving anthracycline- and/or taxane-based adjuvant chemotherapy 期刊论文
2018, 卷号: 37, 期号: 1, 页码: 4
作者:  Li, Meiying;  Ma, Fei;  Wang, Jiayu;  Li, Qing;  Zhang, Pin
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace